Skip to main content

Peer Review reports

From: Real life evaluation of the multi-organ effects of Lumacaftor/Ivacaftor on F508del homozygous cystic fibrosis patients

Original Submission
26 Apr 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Jun 2022 Reviewed Reviewer Report - Slobodan Janković
19 Jul 2022 Reviewed Reviewer Report
1 Sep 2022 Author responded Author comments - Galit Livnat
Resubmission - Version 4
1 Sep 2022 Submitted Manuscript version 4
13 Sep 2022 Author responded Author comments - Galit Livnat
Resubmission - Version 5
13 Sep 2022 Submitted Manuscript version 5
20 Sep 2022 Reviewed Reviewer Report
20 Sep 2022 Reviewed Reviewer Report - Slobodan Janković
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
22 Sep 2022 Editorially accepted
20 Oct 2022 Article published 10.1186/s40360-022-00624-z

You can find further information about peer review here.

Back to article page